4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-24-025921
SVP, CFO acquired 5,251 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Daphne SVP, CFO | 2024-03-02 | Option exercise | +3,667 | 16,827 | D | ||
| Taylor Daphne SVP, CFO | 2024-03-04 | Option exercise | +1,584 | 18,411 | D | ||
| Derivatives | |||||||
| Taylor Daphne SVP, CFO | 2024-03-02 | Option exercise · Restricted Stock Unit | −3,667 | 7,333 | D | ||
| Taylor Daphne SVP, CFO | 2024-03-04 | Option exercise · Restricted Stock Unit | −1,584 | 1,583 | D | ||
Loading xslF345X05/ownership.xml…